<DOC>
	<DOCNO>NCT02320045</DOCNO>
	<brief_summary>A Phase 1 study evaluate pharmacokinetics ITCA 650 subject mild moderate renal impairment compare pharmacokinetics subject normal renal function</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetics ITCA 650 Subjects With Renal Impairment Compared Normal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Body mass index 22 40 kg/m² Subjects meeting predefined estimate glomerular filtration rate criterion creatinine clearance rate Normal ( ≥90 mL/min/1.73 m2 ) Mild ( 6089 mL/min/1.73 m2 ) Moderate ( 4559 mL/min/1.73 m2 ) Moderate ( &gt; 3044 mL/min/1.73 m2 ) History acute metabolic complication Uncontrolled Hypertension History Hypersensitivity Exenatide Cardiovascular Disease History Acute chronic pancreatitis Personal family history Multiple endocrine neoplasia type 2 History Medullary thyroid cancer Severe renal failure , End stage renal disease dialysis</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>